since systemically administered acyclovir may shorten the disease course and reduce the complications of herpes zoster in immunocompromised individuals , the authors favor treatment of all such patients who have herpes zoster ophthalmicus with a seven-day course of high-dose ( 30 mg/kg/day ) intravenous acyclovir .
C0019360
herpes zoster
C0001367
acyclovir